Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins

Kidney International

Volumn 55, Issue 4, 1999, Pages 1359-1366

  Mondorf, Ulrich F ^a,b   Piiper, Albrecht ^a   Herrero, Martina ^a   Olbrich, Hans Georg ^a   Bender, Michael ^a   Gross, Werner ^a   Scheuermann, Ernst ^a   Geiger, Helmut ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cell signaling; End stage renal disease; Glomerulosclerosis; Hyperlipidemia; Inositol phosphates

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM ION; DEXTRAN SULFATE; FURA 2; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; LIPOPROTEIN A; MYC PROTEIN; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROTEIN C FOS; VASOPRESSIN;

ARTICLE; BINDING KINETICS; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME BINDING; ENZYME MECHANISM; GROWTH STIMULATION; HUMAN; HUMAN CELL; MESANGIUM CELL; MITOSIS INHIBITION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM;

EID: 0032920010     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00367.x     Document Type: Article

References (42)

1. KEANE WF, MULCAHY WS, KASISKE BL, O'DONNELL MP:Hyperlipidemia and progressive renal disease. Kidney Int 39:41-43, 1991
2. DIAMOND JR, KARNOVSKY MJ: A putative role of hypercholesterolemia in progressive glomerular injury. Annu Rev Med 43:83-92, 1992
3. KASISKE BL, O'DONNELL MP, KEANE WF: Pharmacologie treatment of hyperlipidemia reduces glomerular injury in the rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62:367-374, 1988
4. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rat. Kidney Int 33:667-672, 1988
5. UTERMANN G, MENZEL HJ, KRAFT HG, DUBA HC, KEMMLER HG, SEITZ C: Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 80:458-465, 1992
6. KRONENBERG F, KOENIG P, NEYER U, AUINGER M, PRIBASNIG A, LANG U, RETTINGER J, PINTER G, UTERMANN G, DIEPLINGER H: Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 6:110-120, 1995
7. KRONENBERG F, TRENKWALDER E, LINGENHEL A, FRIEDRICH G, LHOTTA K, SCHOBER M, MOES N, KOENIG P, UTERMANN G, DIEPLINGER H: Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation. J Lipid Res 38:1755-1763, 1997
8. FAUCHER C, DOUCET C, BAUMELOU A, CHAPMAN J, JACOBS C, THILLET J: Elevated lipoprotein(a) levels in primary nephrotic syndrome. Am J Kidney Dis 22:808-813, 1993
9. THOMAS ME, FREESTONE A, VARGHESE Z, PEKSAUD JW, MOORHEAD JF: Lipoprotein(a) in patients with proteinuria. Nephrol Dial Transplant 7:597-601, 1992
10. WANNER C, RADER D, BARTENS W, KRÄMER J, BREWER HB, SCHOLMEYER P, WIELAND H: Elevated plasma lipoprotein (a) in patients with nephrotic syndrome. Ann Intern Med 119:263-269, 1993
11. STENVINKEL P, BERGLUND L, HEIMBÜRGER O, PEITERSEN E, ALVESTRAND A: Lipoprotein (a) in nephrotic syndrome. Kidney Int 44:1116-1123, 1993
12. HEIMBÜRGER O, STENVINKEL P, BERGLUND L, TRANEUS A, LINDHOLM B: Increased plasma lipoprotein (a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of protein and glucose. Nephron 72:135-144, 1996
13. SATO H, SUZUKI S, UENO M, SHIMADA H, KAEASAWA R, NISHI S, ARAKAWA M: Localisation of apolipoprotein(a) and B-100 in various renal disease. Kidney Int 43:430-435, 1993
14. SAMUELSSON O, ATTMAN P-O, KHIGHT-GIBSON C, LARSSON R, MULEC H, WEDEL H, WEISS L, ALAUPOVIC P: Plasma levels of lipoprotein(a) do not predict progression of human chronic renal failure. Nephrol Dial Transplant 11:2237-2243, 1996
15. KRAMER-GUTH A, GREIBER S, PAVENSTADT H, QUASCHNING T, WINKLER K, SCHOLLMEYER P, WANNER C: Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix. Kidney Int 49:1250-1261, 1996
16. GREIBER S, KRAMER-GUTH A, PAVENSTADT H, GUTENKUNSI M, SCHOLLMEYER P, WANNER C: Effects of lipoprotein(a) on mesangial cell proliferation and viability. Nephrol Dial Transplant 11:778-785, 1996
17. PFEILSCHIETER J, HUWILER A, BRINER VA: Proliferative mechanisms in kidney cells. Curr Opin Nephrol Hypertens 4:98-103, 1995
18. GROSS E, MAERZ W, SIEKMEIER R, SCHARRER J, GROSS W: Isolation of lipoprolein(a) using the regenerate of a dextran sulfate cellulose LDL apharesis system. Protein Expr Purif 3:112-117, 1993
19. McFARLANE AS: Efficient trace labeling of proteins with iodine. Nature 182:53-56, 1958
20. BILHEIMER DW, EISENBERG S, LEVY RI: The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 260:212-221, 1972
21. GOLDSTEIN JL, SANDIP KP, BROWN MS: Receptor mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-260, 1983
22. GRYNKIEWICZ G, POENIE M, TSIEN R: A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
23. n-2 proteins in isolated pancreatic acinar membranes. Am J Physiol 272:G1276-G1284, 1997
24. BRADFORD MM: A rapid and sensitive method for the quantitation of micrograms of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
25. RIDKER PM, HENNEKENS CH, STAMPFER MJ: A prospective study of lipoprotein (a) and the risk of myocardial infarction. JAMA 270:2195-2199, 1993
26. BARTENS W, NAUCK M, SCHOLLMEYER P, WANNER C: Elevated lipoprotein(a) and fibrinogen serum levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 16:27-33, 1996
27. KRONENBERG F, KOENIG P, LHOTTA K, OFNER D, SANDHOLZER C, MARGREITER R, DOSCH E, UTERMANN G, DIEPLINGER H: Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 14:1399-1404, 1994
28. STENVINKEL P, HEIMBÜRGER O, TUCK CH, BERLUND L: Apo(a)isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 53:1336-1342, 1998
29. GUPTA S, RIFICI V, CROWLEY S, BROWNLEE M, ZIHE S, SCHLOENDORFF D: Interaction of LDL and modified LDL with mesangial cells and matrix. Kidney Int 41:1161-1169, 1992
30. WASSERMANN J, SANTIAGO A, RIFICI V, HOLTROFER H, SCHARSCHMIDT L, EPSTEIN M, SCHLOENDORFF D: Interactions of low density lipoproteins with rat mesangial cells. Kidney Int 35:1168-1174, 1989
31. WHEELER DC, GHANA RS: Interactions between iipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 19:149-164, 1993
32. BOTTALICO LA, KEESLER GA, FLESS GM, TABAS I: Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. J Biol Chem 268:8569-8573, 1993
33. SNYDER LS, POLACEK D, SCANU AM, FLESS GM: Comparative binding and degradation of lipoprolein(a) and low density lipoprotein by human monocyte-derived macrophages. J Biol Chem 267:339-346, 1992
34. KOSTNER GM, GRILLHOFER HG: Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. J Biol Chem 266:21287-21292, 1991
35. KRAMER A, NAUCK M, PAVENSTADT H, SCHWEDLER S, WIELAND H, SCHOLLMEYER P, WANNER C: Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells. Kidney Int 44:1341-1351, 1993
36. KRAMER GUTH A, NAUCK M, QUASCHNING T, PAVENSTADT H, WIELAND H, SCHOLLMEYER P, WANNER C: VLDL and LDL metabolism in human and rat mesangial cells. Nephron 74:378-385, 1996
37. STIKO RAHM A, HULTGARDH NILSSON A, REGNSTROM J, HAMSTEN A, NILSSON J: Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb 12:1099-1109, 1992
38. O'DONNELL MP, KASISKE BL, KIM Y, ATLURU D, KEANE WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 91:83-87, 1993
39. BOCHKOV V, TKACHUK V, BUHLER F, RESINK T: Phosphoinositide and calcium signaling responses in smooth muscle cells: Comparison between lipoproteins, Ang 11, and PPGF. Biochem Biophys Res Commun 188:1295-1304, 1992
40. SCHAEFER HI, HOLD KM, EGAS-KENNIPHAAS JM, VAN-DER-LAARSE A: Intracellular calcium signaling after binding of low-density lipoprotein to confluent and nonconfluent cultures of an endothelial cell line, EA.hy 926. Cell Calcium 14:507-516, 1993
41. RHEE SG, BAE YS: Regulation of phosphoinositide-specific phospholipase C isoenzymes. J Biol Chem 272:15045-15048, 1997
42. PORTILLA D, MORDHORST M, BERTRAND W, IRWIN C, MORRISON AR: Different guanosine triphosphate-binding proteins couple vasopressin receptor to phospholipase C and phospholipase A2 in glomerular mesangial cells. J Lab Clin Med 120:752-761, 1992